Hong Kong stocks surged | Pegasus Biomedical-B (02565.HK) rose by more than 6%; the first batch of commercialized prescriptions for Paidacan landed nationwide, receiving a second equity investment of approximately 49 million Hong Kong dollars.
According to the Securities Times app, Pegasus Pharmaceuticals-B (02565.HK) rose more than 6%, with an increase of 6.1% as of the time of writing, reaching 7.48 Hong Kong dollars, with a trading volume of 30.1567 million Hong Kong dollars.
Latest
4 m ago
